Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.00
-0.03 (-0.37%)
At close: Jun 26, 2026, 4:00 PM EDT
8.00
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
Arvinas Employees
Arvinas had 246 employees as of December 31, 2025. The number of employees decreased by 184 or -42.79% compared to the previous year.
Employees
246
Change (1Y)
-184
Growth (1Y)
-42.79%
Revenue / Employee
$363,415
Profits / Employee
-$899,593
Market Cap
516.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Kyverna Therapeutics | 129 |
| Ocugen | 116 |
| Assembly Biosciences | 73 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
| Contineum Therapeutics | 51 |
ARVN News
- 2 days ago - Arvinas Transcript: AGM 2026 - Transcripts
- 23 days ago - Arvinas Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Arvinas to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Arvinas Employees Give Back During Company-wide Impact Day - GlobeNewsWire
- 6 weeks ago - Arvinas price target raised to $16 from $14 at BofA - TheFly
- 6 weeks ago - Arvinas price target raised to $18 from $16 at BTIG - TheFly
- 6 weeks ago - Arvinas price target raised to $20 from $18 at Barclays - TheFly
- 6 weeks ago - H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’ - TheFly